ViiV Healthcare seeks USFDA approval to expand Cabenuva use for HIV-1 infected adults

Specialist HIV company ViiV Healthcare has submitted a supplemental new drug application (sNDA) to the US Food and Drug Administration (FDA) to expand the use of Cabenuva.